-
CPRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Catalyst Pharmaceuticals (CPRX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 312 |
Opened positions | 65 |
Closed positions | 24 |
Increased positions | 96 |
Reduced positions | 105 |
13F shares | Current |
---|---|
Total value | 1.81 tn |
Total shares | 101.52 mm |
Total puts | 51.10 k |
Total calls | 19.10 k |
Total put/call ratio | 2.7 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 19.02 mm | $378.07 bn |
Vanguard | 8.04 mm | $159.85 bn |
Deerfield Management | 6.23 mm | $123.85 bn |
Flynn James E | 6.23 mm | $134.31 mm |
STT State Street | 5.69 mm | $113.02 bn |
Dimensional Fund Advisors | 3.02 mm | $60.01 bn |
Pacer Advisors | 2.80 mm | $55.74 bn |
Geode Capital Management | 2.66 mm | $52.98 bn |
Renaissance Technologies | 2.53 mm | $50.22 bn |
First Trust Advisors | 2.43 mm | $48.29 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jan 25 | Donald A Denkhaus | Common Stock, par value $0.001 per share | Option exercise | Acquire M | No | No | 2.24 | 50,000 | 112.00 k | 491,079 |
8 Jan 25 | Donald A Denkhaus | Options to purchase common stock Common Stock | Option exercise | Dispose M | No | No | 2.24 | 50,000 | 112.00 k | 162,274 |
2 Jan 25 | Michael Wayne Kalb | Common Stock, par value $0.001 per share | Payment of exercise | Dispose F | No | No | 0 | 2,941 | 0.00 | 4,197 |
2 Jan 25 | Michael Wayne Kalb | Common Stock, par value $0.001 per share | Option exercise | Acquire M | No | No | 0 | 7,138 | 0.00 | 7,138 |
2 Jan 25 | Michael Wayne Kalb | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 7,138 | 0.00 | 475,699 |
2 Jan 25 | Richard J Daly | Common Stock, par value $0.001 per share | Payment of exercise | Dispose F | No | No | 0 | 10,600 | 0.00 | 267,338 |
2 Jan 25 | Richard J Daly | Common Stock, par value $0.001 per share | Option exercise | Acquire M | No | No | 0 | 42,105 | 0.00 | 277,938 |
2 Jan 25 | Richard J Daly | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 42,105 | 0.00 | 2,238,753 |
27 Dec 24 | Steve Miller | Common stock, par value $0.001 per share | Option exercise | Acquire M | No | No | 0 | 14,000 | 0.00 | 935,996 |
27 Dec 24 | Steve Miller | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 14,000 | 0.00 | 1,538,176 |